Community
/
Blog
/
Article
Blog Article

Partnering with Pure Global Singapore

With a population of 5+ million, Singapore has the highest GDP per capita in Asia, according to Trading Economics.

Written by:
Published on:
August 15, 2024

Market potential

With a population of over 5 million, Singapore boasts the highest GDP per capita in Asia, according to Trading Economics. Its medical device market is one of the largest and most advanced in Southeast Asia, making it an ideal destination for high-end innovative products. Many renowned medical device multinational corporations have established their regional headquarters in Singapore. According to a report by Mordor Intelligence, the market was valued at USD 1.5 billion in 2020 and is expected to grow to USD 2.3 billion by 2026, with a CAGR of 7.2% during the forecast period (2021-2026). This impressive growth is fueled by Singapore's aging population, the rising prevalence of chronic diseases, and the government's initiatives to expand its healthcare infrastructure. Over the next five years, at least eight new nursing homes, 10 polyclinics, and a new hospital are planned, with more developments anticipated by 2030.

Due to its small land area and limited local manufacturing, Singapore imports the majority of its medical devices, offering significant opportunities for overseas manufacturers. For companies looking to tap into this growing market, expert guidance is essential. Our medical device regulatory consulting services provide the support needed to navigate Singapore’s regulatory environment, ensuring smooth market entry and long-term success in this thriving market.

Overview of the regulatory system

Medical devices are regulated under the Health Products Act and Health Products (Medical Devices) regulations.  Singapore’s Health Sciences Authority (HSA) oversees the system of statutory control aimed to safeguard the quality, safety, and efficacy of medical devices available in Singapore.  Almost all medical devices are regulated.  Class A medical devices supplied in a non-sterile state are exempted, however, Class B, C, and D medical devices are subject to product registration requirements.  Classification rules are adopted from the guidance developed by the Global Harmonization Task Force (GHTF).

Product registration is done by a “registrant”, defined as a person or company who applied for and obtained the registration of the medical device under the Health Products Act.. A registrant of a medical device has to fulfil the duties and obligations prescribed under the Act and Health Products (Medical Devices) Regulations.

Singapore – Gateway to Southeast Asia’s 600+ million population

Although small in size,  Singapore’s competitive advantage such as a highly skilled labour force, and high quality physical and digital infrastructure makes it well known in SEA and beyond. Indeed, it is for such reasons that Singapore was chosen to house the Southeast Asia (SEA) headquarters of Pure Global. By working with a single point of contact in Singapore, you will be able to simultaneously register your medical device in the 6 major SEA markets – Singapore, Malaysia, Indonesia, Thailand, Vietnam and Philippines. This saves you invaluable time and gains you speedy access to the 600+ million SEA market.

How can we help you?

We offer a full range of market access services, including HSA Singapore Medical Device Registration. Our process begins with the classification and grouping of your products to determine the specific regulatory requirements. Once you're ready to proceed, we will compile the technical file and ensure all necessary documentation is in order. As your local representative, we handle the submission to the HSA for Singapore Medical Device Registration and provide ongoing support with any post-market follow-up activities needed to ensure continuous regulatory compliance and commercial success.

Subscribe to newsletter
Subscribe to receive the latest blog posts to your inbox every week.
By subscribing, you agree to our Terms and Conditions.
Thank you for subscribing!
Oops! Something went wrong while submitting the form.
Read More

Latest Blog Content

Explore our collection of articles, success stories, and regulatory updates, designed to help you take your product global.

Pure Global 2024 Year in Review
Blog Article
Pure Global 2024 Year in Review

As 2024 comes to a close, Pure Global proudly reflects on a transformative year marked by substantial growth, cutting-edge innovation, and impactful collaborations.

Risk increases compliance chalenges under IVDR
Blog Article
What are the challenges under IVDR?

IVD manufacturers cite the new classification system, detailed definitions for intended purposes, and the need for verification of clinical evidence as key challenges under the IVDR.

Blog Article
EU Parliament Revises MDR and IVDR

On October 23, the European Parliament adopted a resolution revising specific elements of the Medical Devices Regulation (MDR) and the In Vitro Diagnostic Devices Regulation (IVDR). This resolution intends to address ongoing challenges in implementing the regulations by 2025 and to improve patient access to important medical products.

Blog Article
Language Challenges in MedTech Going Global and Our Solution

Multilingual documentation presents ongoing compliance and logistical hurdles for MedTech manufacturers. Transla.Ai is an industry-specific translation tool that can accelerate and streamline the translation process.

Contact us
Request information

Let's Talk,
Anywhere You Are.

Whether looking for more information or ready to partner with us, we're here to guide you through every step of the regulatory process.

Our closest representative will get back to you within 24 hours.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.